Clinical trial
Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag
NCT04269889 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Refractory Diamond-Blackfan Anemia With Eltrombopag
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 1, 2020
- Completion date
- February 16, 2024
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.